Pfizer Inc
PFEView Detailed Chart
22.970USD
-1.300-5.35%
Close 04/04, 16:00（ET）Quotes delayed by 15 min
130.17BMarket Cap
16.21P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-5.35%
5 Days
-8.84%
1 Month
-12.46%
6 Months
-19.62%
Year to Date
-13.41%
1 Year
-13.84%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
23
analysts
HOLD
Current Rating
30.865
Target Price
34.37%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
150
Total
5
Median
7
Average
Company name
Ratings
Analysts
Pfizer Inc
PFE
23
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
BioMarin Pharmaceutical Inc
BMRN
29
1
2
3
...
30
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.488
Sell
RSI(14)
23.770
Sell
STOCH(KDJ)(9,3,3)
4.879
Oversold
ATR(14)
0.567
High Vlolatility
CCI(14)
-190.788
Sell
Williams %R
98.459
Oversold
TRIX(12,20)
-0.229
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Indicators
Value
Direction
MA5
24.370
Sell
MA10
24.894
Sell
MA20
25.482
Sell
MA50
25.888
Sell
MA100
25.980
Sell
MA200
27.460
Sell
Company
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
Company codePFE
CompanyPfizer Inc
CEODr. Albert Bourla, Ph.D.
Websitehttps://www.pfizer.com/
